Companies: 10,795·Total market cap: $144.5T
BIOLASE, Inc.

BIOLASE, Inc.

BIOLNASDAQHealthcare
$0.02
+$0.00(+27.39%)
Market Cap$731942
P/E Ratio
52W High$1.94
52W Low$0.0157
Overview

BIOLASE, Inc.(BIOL)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · BIOL · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-2.24biol eps ttm · biol earnings per shareEarnings history
PE Ratio (TTM)biol pe ratio ttm · biol price to earningsPE Ratio deep dive
Revenue (TTM)$46.0Mbiol revenue ttm · biol annual revenueFull revenue history
Dividend Yield0.81%does biol pay dividends · biol dividend yieldDividend history
Shares Outstanding1.3Mbiol shares outstanding · biol floatShares outstanding history
Next EarningsTBAbiol earnings date · biol next earningsEarnings history

财务快照

完整财报
FY 2023Revenue$49.2M▲ +1.45% YoY
202120222023
biolase, inc. revenue · biol revenue 2023
FY 2023Net Income-$20.6M▲ +27.95% YoY
202120222023
biolase, inc. net income · biol profit 2023
FY 2023EPS$-16.14▲ +96.09% YoY
202120222023
biol eps · biolase, inc. earnings per share 2023
TTM:Revenue: $46.0MNet Income: -$16.0MEPS: $-2.24View income statement →

分析师评级与目标价

完整预测
SellBuy
Buy6 位分析师is biol a buy · biol analyst rating
Strong Buy
0
Buy
5
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$0.02Current
$Avg Target
$High
biol price target · biol 12 month forecast

合计: 6 · 买入占比: 83.3%

股票表现

完整历史
1D+0.00%
1W+150.00%
1M-67.79%
3M-71.43%
YTD-98.18%
1Y-98.81%
5Y-100.00%

关于 BIOLASE, Inc.

CEOJohn R. Beaver
IPO DateNov 12, 1992
Employees157
CountryUS

BIOLASE, Inc. along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are spec…

what is biolase, inc. · biol stock overview · biolase, inc. company profile · who is biolase, inc. ceo · biol NASDAQ · biolase, inc. headquarters · biolase, inc. business segments

关于股票概览与关键数据

BIOLASE, Inc.(BIOL)是 Medical - Devices 行业的 Healthcare 类公司,于 Nov 12, 1992 在 NASDAQ 上市。截至最近交易日,BIOL 股价为 $0.02,市值约为 $731,942。过去12个月累计回报 -98.81%,年初至今回报 -98.18%。

根据 6 位华尔街分析师,BIOLASE, Inc. 股票共识评级为Buy,12个月平均目标价为 $—。2023 财年 BIOLASE, Inc. 营收 $49.2M,净利润 -$20.6M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,BIOLASE, Inc.(BIOL)股价为 $0.02,在 NASDAQ 上市,52周区间为 $0.02 – $1.94。

BIOL 最新股价BIOL quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 8, 2026本内容不构成投资建议